Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$8.18M Sell
233,570
-109,500
-32% -$3.86M 0.08% 239
2014
Q4
$13.1M Buy
343,070
+302,965
+755% +$11.1M 0.14% 184
2014
Q3
$1.42M Buy
40,105
+425
+1% +$15.8K 0.02% 553
2014
Q2
$1.55M Sell
39,680
-332
-0.8% -$12.4K 0.02% 545
2014
Q1
$1.46M Sell
40,012
-25
-0.1% -$912 0.02% 538
2013
Q4
$1.39M Buy
40,037
+1,030
+3% +$33.1K 0.02% 531
2013
Q3
$1.09M Sell
39,007
-307
-0.8% -$8.19K 0.02% 568
2013
Q2
$1.06M Buy
+39,314
New +$1.09M 0.02% 556

Other funds holding XYL

Baird's XYL Position: Q1 2015 in Review

Baird reduced its Xylem (XYL) stake by 32% in Q1 2015, selling an estimated $3.86M and leaving 233,570 shares worth $8.18M. The position accounts for 0.08% of the portfolio, ranked #239.

Baird first reported a position in XYL in Q2 2013 and has held it in 8 quarters since. The position peaked at $13.1M in Q4 2014. 429 funds tracked by Wall St. Rank hold XYL as of Q1 2015.

  • Baird held 233,570 shares of Xylem worth $8.18M as of Q1 2015.
  • Baird sold 109,500 Xylem shares in Q1 2015, an estimated $3.86M.
  • Xylem made up 0.08% of Baird's portfolio in Q1 2015, its #239 holding.
  • Baird first reported a position in Xylem in Q2 2013 and has held it in 8 quarters since.
  • Baird's Xylem position peaked at $13.1M in Q4 2014.
  • 429 funds tracked by Wall St. Rank held Xylem as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.